Analyst Ratings For NASDAQ:MNLO – Menlo Therapeutics (NASDAQ:MNLO)
Today, Guggenheim reiterated its Buy rating on NASDAQ:MNLO – Menlo Therapeutics (NASDAQ:MNLO) with a price target of $11.00.
Some recent analyst ratings include
- 4/25/2018-Guggenheim Reiterated Rating of Buy.
- 4/9/2018-Jefferies Group was Downgraded by analysts at Jefferies Group from a “Buy ” rating to a ” Hold” rating.
- 2/20/2018-JMP Securities initiated coverage with a Mkt Outperform rating.
- 2/20/2018-Piper Jaffray initiated coverage with a Overweight rating.
Recent Trading Activity for NASDAQ:MNLO – Menlo Therapeutics (NASDAQ:MNLO)
Shares of NASDAQ:MNLO – Menlo Therapeutics closed the previous trading session at 7.41 down -0.60 7.50% with 6.989999771118164 shares trading hands.
